Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
continuously (64)
Annual-report-201617
Description
ANNUAL REPORT AND ACCOUNTS 2016/17 incorporating the quality account 2016/17 Presented to Parliament pursuant to Sche
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2016171.pdf
Gemcitabine
Description
Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE Regimen Pancreatic Cancer – Gemcitabine Indication Adjuvant treatment of pancreat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine.pdf
Inotuzumab Ozogamicin
Description
Relapsed or refractory CD22-positive B-Cell acute lymphoblastic leukaemia.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Inotuzumab-Ozogamicin.pdf
Heart palpitations - patient information
Description
This factsheet explains what heart palpitations are and what causes them.
Url
/Media/UHS-website-2019/Patientinformation/Generalmedicine/Heart-palpitations-3140-PIL.pdf
Durvalumab(28day-1500mg)
Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC - Durvalumab (28 day – 1500mg) Indication • Durvalumab is i
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf
Gemcitabine
Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) GEMCITABINE Regimen NSCLC - Gemcitabine Indication Second line therapy of stag
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Gemcitabinever12.pdf
Gemcitabine RT ver1
Description
Chemotherapy Protocol BLADDER CANCER GEMCITABINE RT Regimen Bladder – Gemcitabine RT Indication The treatment of muscle invasive bladder
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-RT-ver1.pdf
Gemcitabine (21day) ver1.1
Description
Chemotherapy Protocol BLADDER GEMCITABINE (21 day) Regimen Bladder-Gemcitabine Indication Locally advanced or metastatic urothelial can
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Gemcitabine-21day-ver1.1.pdf
Docetaxel (30)-Prednisolone ver1.1
Description
Chemotherapy Protocol PROSTATE DOCETAXEL(30)-PREDNISOLONE Regimen Prostate-Docetaxel (30)-Prednisolone Indication Advanced castrate res
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Docetaxel-30-Prednisolone-ver1.1.pdf
Vinorelbine (intravenous)
Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf
291
to
300
of
733
Previous
…
28
29
30
31
32
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.